Zhou Jiang, Research Scientist at MD Anderson Cancer Center, shared a post on LinkedIn:
“Legends in the room.
It was a privilege to attend this gathering hosted by Dr. Katy Rezvani at MD Anderson. I am sincerely grateful for the generous support and collaborative environment her lab provides, which has been essential for my research.
Wonderful to reconnect with Dr. Lewis Lanier (UCSF). He is a giant in our field, and I deeply appreciate his trust and support at the pivotal moment in my career.
And a true honor to speak with Dr. Carl June.
I shared with him how his pioneering work in CAR-T inspired my own transition from Innate Immunity to my current focus on Solid Tumors (TNBC).
We discussed the challenges ahead, and I felt deeply encouraged by his attention and insights.
The road to curing solid tumors is long, but we will see.”
More from MD Anderson Cancer Center on OncoDaily.